Our Lady of The Lake Regional Medical Center

Cytovale's IntelliSep Diagnostic Reduces Sepsis Mortality by 39% in Large Real-World Study

- Cytovale's FDA-cleared IntelliSep diagnostic achieved a 39% relative reduction in sepsis mortality in a real-world study of over 12,000 patients at Our Lady of the Lake Regional Medical Center. - The rapid diagnostic test delivers results in eight minutes from a routine blood draw and reduced average hospital length of stay by 0.76 days for sepsis patients. - The study demonstrated improved resource allocation with a 40% decrease in blood culture usage for low-risk patients and an 8% increase for high-risk cases. - Following successful validation, the health system has expanded IntelliSep implementation across four additional sites within Franciscan Missionaries of Our Lady Health System.